0P48

Moberg Pharma Ab (publ) (0P48)

Moberg Pharma Ab (publ)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0P48

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
05/17/2024	3:00PM	iHub Newswire	FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
02/07/2024	2:12AM	UK Regulatory	MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication	LSE:0P48	Moberg Pharma Ab (publ)
02/07/2024	2:10AM	UK Regulatory	MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication	LSE:0P48	Moberg Pharma Ab (publ)
06/28/2023	5:23AM	PR Newswire (US)	MOB-015 is recommended for approval in EU: Moberg Pharma	LSE:0P48	Moberg Pharma Ab (publ)
03/28/2022	2:10AM	PR Newswire (US)	European marketing authorization application for MOB-015 submitted	LSE:0P48	Moberg Pharma Ab (publ)
12/23/2021	2:12AM	PR Newswire (US)	The Medical Products Agency in Sweden will be reference member state for Moberg Pharma's European registration application	LSE:0P48	Moberg Pharma Ab (publ)
09/22/2021	2:22AM	PR Newswire (US)	Moberg Pharma receives approval from the EMA's Paediatric Committee	LSE:0P48	Moberg Pharma Ab (publ)
02/09/2021	2:13AM	PR Newswire (US)	Moberg Pharmas Year-end report 2020	LSE:0P48	Moberg Pharma Ab (publ)
01/29/2021	7:23AM	PR Newswire (US)	Moberg Pharma: Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record...	LSE:0P48	Moberg Pharma Ab (publ)
01/29/2021	2:37AM	PR Newswire (US)	New number of shares and votes in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
01/07/2021	2:08AM	PR Newswire (US)	OncoZenge announces issue of European Patent related to BupiZenge®	LSE:0P48	Moberg Pharma Ab (publ)
12/11/2020	2:07AM	PR Newswire (US)	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	LSE:0P48	Moberg Pharma Ab (publ)
11/30/2020	8:33AM	PR Newswire (US)	Moberg Pharma obtains positive decision from the Swedish Tax Agency regarding the Lex Asea distribution of the shares in Onco...	LSE:0P48	Moberg Pharma Ab (publ)
11/23/2020	2:41AM	PR Newswire (US)	Invitation to market update in Moberg Pharma on November 25th	LSE:0P48	Moberg Pharma Ab (publ)
11/16/2020	9:16AM	PR Newswire (US)	OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing	LSE:0P48	Moberg Pharma Ab (publ)
11/10/2020	3:02AM	PR Newswire (US)	Extended fiscal year July 2019 - December 2020 Interim report July - September 2020	LSE:0P48	Moberg Pharma Ab (publ)
11/06/2020	2:26AM	PR Newswire (US)	Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 million	LSE:0P48	Moberg Pharma Ab (publ)
11/06/2020	2:25AM	PR Newswire (US)	Moberg Pharma intends to distribute and separately list BupiZenge® (BUPI)	LSE:0P48	Moberg Pharma Ab (publ)
10/14/2020	2:27AM	PR Newswire (US)	Moberg Pharma intends to submit a registration application in Europe in 2021	LSE:0P48	Moberg Pharma Ab (publ)
10/14/2020	2:24AM	PR Newswire (US)	Moberg Pharma intends to submit a registration application in Europe in 2021	LSE:0P48	Moberg Pharma Ab (publ)
08/11/2020	2:16AM	PR Newswire (US)	Moberg Pharma: Interim report April - June 2020	LSE:0P48	Moberg Pharma Ab (publ)
07/30/2020	2:27AM	PR Newswire (US)	Appointment of Chief Medical Officer at Moberg Pharma	LSE:0P48	Moberg Pharma Ab (publ)
06/30/2020	2:28AM	PR Newswire (US)	New number of Shares and Votes in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
06/25/2020	2:26AM	PR Newswire (US)	Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study	LSE:0P48	Moberg Pharma Ab (publ)
06/25/2020	2:23AM	PR Newswire (US)	Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study	LSE:0P48	Moberg Pharma Ab (publ)
05/29/2020	2:13AM	PR Newswire (US)	New Number of Shares and Votes in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
05/12/2020	2:24AM	PR Newswire (US)	Extended Fiscal Year July 2019 - December 2020 Interim Report January - March 2020	LSE:0P48	Moberg Pharma Ab (publ)
05/05/2020	2:14AM	PR Newswire (US)	Moberg Pharma's Interim Report for July 2019 - March 2020 to be Published on May 12 - Invitation to Teleconference	LSE:0P48	Moberg Pharma Ab (publ)
03/27/2020	4:20AM	PR Newswire (US)	Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)	LSE:0P48	Moberg Pharma Ab (publ)
03/23/2020	4:17PM	PR Newswire (US)	Moberg Pharma Enters Financing Agreement of Up To SEK 216 Million for Further Investments in MOB-015	LSE:0P48	Moberg Pharma Ab (publ)